TY - JOUR
T1 - Diagnostic Evaluation and Clinical Findings in Children with Persistent Tachypnea of Infancy/neuroendocrine Cell Hyperplasia of Infancy
T2 - A European Multicenter Retrospective Study
AU - Marczak, Honorata
AU - Krenke, Katarzyna
AU - Griese, Matthias
AU - Peradzyńska, Joanna
AU - Lange, Joanna
AU - Kulus, Marek
AU - Grochowska, Magdalena
AU - Seidl, Elias
AU - Dubus, Jean-Christophe
AU - Rodler, Julia
AU - Schwerk, Nicolaus
AU - Carlens, Julia
AU - Breuer, Oded
AU - Hevroni, Avigdor
AU - Castillo-Corullón, Silvia
AU - Aldeco, Malena
AU - Buchvald, Frederik Fouirnaies
AU - Nielsen, Kim G
AU - Mayell, Sarah
AU - Torrent, Alba
AU - Bravo-López, Maynor
AU - Regamey, Nicolas
AU - Florian, Stehling
AU - Latzin, Philipp
AU - Zschocke, Anna
AU - Hatziagorou, Elpis
AU - Ayats, Roser
AU - Eyüboğlu, Tuğba Şişmanlar
AU - Erdem, Ela
AU - Proesmans, Marijke
AU - Cunningham, Steve
AU - Moriki, Dafni
AU - Pekcan, Sevgi
AU - Cobanoglu, Nazan
AU - Naehrlich, Lutz
AU - Lex, Christiane
AU - Ullmann, Nicola
AU - Baden, Winfried
AU - Krikovszky, Dora
AU - Gaboli, Mirella
AU - Diez Monge, Nuria
AU - Naranjo Vivas, David
AU - Leisgaard Mørck Rubak, Sune
AU - Willemse, Brigitte
AU - Petrarca, Laura
AU - Wiemers, Anna
AU - Schramm, Dirk
AU - Mueller, Christoph
AU - Prenzel, Freerk
AU - Koucky, Vaclav
AU - López-Andreu, Juan A
AU - Nathan, Nadia
N1 - Copyright © 2025. Published by Elsevier Inc.
PY - 2025/7
Y1 - 2025/7
N2 - BACKGROUND: Persistent tachypnea of infancy (PTI) or neuroendocrine cell hyperplasia of infancy (NEHI) is a form of childhood interstitial lung disease (chILD) that predominantly affects young children. Although it is one of the most common chILDs, no unified diagnostic approach specific to this condition exists.RESEARCH QUESTION: Are the clinical presentation and the diagnostic approach different in patients with PTI/NEHI among European countries?STUDY DESIGN AND METHODS: This was a European multicenter, retrospective, observational study. Data on clinical characteristics and diagnostic strategies in patients with PTI/NEHI were analyzed and compared across participating countries.RESULTS: The study included 378 children with PTI/NEHI from 17 countries (63.5% male, 97.4% White) who received a diagnosis at a median age of 9 months (interquartile range, 6-13 months). The most common baseline symptoms were tachypnea, chest retractions, crackles on auscultation, hypoxemia, and failure to thrive. High-resolution CT (HRCT) imaging was performed in all patients, with most undergoing chest radiography, echocardiography, and immunology tests. Lung biopsy was carried out in 23.5% of patients, with a decreasing trend over time and variation by country; its use was associated with longer diagnostic delay. Histopathologic examination showed a hyperplasia of pulmonary neuroendocrine cells in 52.8% of patients. Genetic testing was rare, and its application varied significantly among countries. Additional investigations that do not have an established role, such as assessment for gastroesophageal reflux disease and OSA, infant pulmonary function tests, and lung ultrasound, were limited to single countries.INTERPRETATION: Diagnosis of PTI/NEHI relies on clinical symptoms and HRCT imaging results, with lung biopsies less commonly performed. Differences exist among countries regarding the number and type of investigations. A need exists for guidelines that will standardize the diagnostic approach.
AB - BACKGROUND: Persistent tachypnea of infancy (PTI) or neuroendocrine cell hyperplasia of infancy (NEHI) is a form of childhood interstitial lung disease (chILD) that predominantly affects young children. Although it is one of the most common chILDs, no unified diagnostic approach specific to this condition exists.RESEARCH QUESTION: Are the clinical presentation and the diagnostic approach different in patients with PTI/NEHI among European countries?STUDY DESIGN AND METHODS: This was a European multicenter, retrospective, observational study. Data on clinical characteristics and diagnostic strategies in patients with PTI/NEHI were analyzed and compared across participating countries.RESULTS: The study included 378 children with PTI/NEHI from 17 countries (63.5% male, 97.4% White) who received a diagnosis at a median age of 9 months (interquartile range, 6-13 months). The most common baseline symptoms were tachypnea, chest retractions, crackles on auscultation, hypoxemia, and failure to thrive. High-resolution CT (HRCT) imaging was performed in all patients, with most undergoing chest radiography, echocardiography, and immunology tests. Lung biopsy was carried out in 23.5% of patients, with a decreasing trend over time and variation by country; its use was associated with longer diagnostic delay. Histopathologic examination showed a hyperplasia of pulmonary neuroendocrine cells in 52.8% of patients. Genetic testing was rare, and its application varied significantly among countries. Additional investigations that do not have an established role, such as assessment for gastroesophageal reflux disease and OSA, infant pulmonary function tests, and lung ultrasound, were limited to single countries.INTERPRETATION: Diagnosis of PTI/NEHI relies on clinical symptoms and HRCT imaging results, with lung biopsies less commonly performed. Differences exist among countries regarding the number and type of investigations. A need exists for guidelines that will standardize the diagnostic approach.
KW - chILD
KW - childhood interstitial lung disease
KW - NEHI
KW - neuroendocrine cell hyperplasia of infancy
KW - persistent tachypnea of infancy
KW - PTI
KW - Tomography, X-Ray Computed/methods
KW - Humans
KW - Male
KW - Infant
KW - Europe/epidemiology
KW - Lung Diseases, Interstitial/diagnosis
KW - Hyperplasia/diagnosis
KW - Biopsy
KW - Lung/pathology
KW - Female
KW - Retrospective Studies
KW - Neuroendocrine Cells/pathology
KW - Tachypnea/diagnosis
UR - http://www.scopus.com/inward/record.url?scp=105007425575&partnerID=8YFLogxK
U2 - 10.1016/j.chest.2025.02.023
DO - 10.1016/j.chest.2025.02.023
M3 - Journal article
C2 - 40054602
SN - 0012-3692
VL - 168
SP - 171
EP - 182
JO - Chest
JF - Chest
IS - 1
ER -